Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination-Reference-Cited by-同舟云学术

Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination

Published:2023-01 Issue:1 Volume:29 Page:105-108
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Sakayori Masashi^ORCID,Hagiwara Eri,Baba Tomohisa,Kitamura Hideya,Sekine Akimasa,Ikeda Satoshi,Tabata Erina^ORCID,Yamada Sho^ORCID,Fujimoto Kazushi,Ogura Takashi

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference14 articles.

1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet (London, England),2021

4. Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination;DeDent;Thorax,2022

5. COVID-19 vaccine induced interstitial lung disease;Yoshifuji;J Infect Chemother,2022

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with interstitial lung disease;COVID-19: An Update;2024-09-01

2. Spontaneous regression of acute fibrinous organizing pneumonia induced by COVID-19 vaccination: A case report;Respiratory Investigation;2024-05

3. A Lethal Case of Acute Exacerbation of Rheumatoid Arthritis – Related Interstitial Lung Disease Induced by the COVID Vaccine.;Respiratory Medicine Case Reports;2023-12

4. Risk factors associated with COVID‐19 pneumonia in Chinese patients with pre‐existing interstitial lung disease during the SARS‐CoV‐2 pandemic;Journal of Medical Virology;2023-09

5. Tozinameran;Reactions Weekly;2023-03-04